ALBANY MOLECULAR RESH INC's ticker is and the CUSIP is 012423AB5. A total of 18 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,651,000 | – | 13,100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,500,000 | $10,083,000 | 9.46% |
| Context Capital Management, LLC | 6,575,000 | $7,787,000 | 7.57% |
| Mohican Financial Management, LLC | 4,500,000 | $5,302,000 | 5.80% |
| Verition Fund Management LLC | 3,000,000 | $3,549,000 | 0.38% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,150,000 | $2,534,000 | 0.37% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 20,000,000 | $23,642,000,000 | 0.35% |
| SSI INVESTMENT MANAGEMENT LLC | 3,364,000 | $3,964,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,903,000 | $17,636,000 | 0.26% |
| CSS LLC/IL | 3,700,000 | $4,370,000 | 0.21% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,582,000 | $5,424,000 | 0.19% |